Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Lumiera Health NHPHF


Primary Symbol: V.NHP

Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.


Recent & Breaking News (TSXV:NHP)

Lumiera Health (TSXV:NHP) partners with natural health industry leader

John Ballem  6 days ago

Lumiera enters MOU with Natural Health Industry Leader for Strategic Partnership and Licensing Agreement

Canada NewsWire 6 days ago

Lumiera reports first half of 2022 results with a 40% increase compared to previous year

Canada NewsWire July 5, 2022

Lumiera Health launches US sales of Awaye pain relief cream with first shipment to Amazon.com

Canada NewsWire June 9, 2022

Lumiera reports second quarter 2022 results with a 28% increase compared to previous year

Canada NewsWire June 1, 2022

Lumiera Health expands retail footprint of Awaye(TM) pain relief across Quebec with Sobeys' Rachelle Béry

Canada NewsWire May 26, 2022

Lumiera announces the results of its annual meeting

Canada NewsWire May 20, 2022

Lumiera Health files new NPN application with Health Canada to extend Awaye Pain Relief product line

Canada NewsWire May 4, 2022

Lumiera Health expands online distribution with Bazzzics(TM) sleep-aids on Amazon and Well.ca

Canada NewsWire March 31, 2022

Lumiera Health Inc. (TSXV:NHP) signs distribution agreement with Fideschem International Ltd.

John Ballem  March 25, 2022

Lumiera Health signs distribution agreement to launch Awaye(TM) in Vietnam - a market of 100 million people

Canada NewsWire March 24, 2022

Lumiera begins fiscal year strong with +25% growth in Q1 2022 compared to previous year

Canada NewsWire March 22, 2022

Lumiera Health signs definitive agreement to launch Awaye(TM) in the US and receives NDC from FDA

Canada NewsWire March 8, 2022

Lumiera Health changes their debt structure to allocate more cash for accelerated growth

Canada NewsWire February 25, 2022

As part of US expansion plans Lumiera Health Appoints Jacqueline Khayat to Board of Directors

PR Newswire February 22, 2022

Lumiera Health signs binding term sheet to launch Awaye(TM) pain relief cream in the US

PR Newswire February 15, 2022

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

Accesswire December 2, 2021

Lumiera (TSXV:NHP) ends fiscal year on a high note with strong sales in November

John Ballem  December 2, 2021

Lumiera ends fiscal year strong with sales in November 2021 up 59% compared to November 2020

PR Newswire December 2, 2021

Lumiera Health Appoints Louis Doyle to Board of Directors

PR Newswire November 18, 2021